Thanks Brian, I remember running my ruler over this stock many years ago.
The value proposition seemed too good to be true back then, glad I listened to my gut and stayed away. GPR SP performance has been a shocker.
Not a fan of PNG either.
- Forums
- ASX - By Stock
- GPR
- Ann: Woodlark Scoping Study forecasts strong financial returns
Ann: Woodlark Scoping Study forecasts strong financial returns, page-3
Featured News
Add GPR (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
-0.002(7.41%) |
Mkt cap ! $29.57M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.5¢ | $16.78K | 660.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1064763 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 185538 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1064763 | 0.025 |
5 | 830780 | 0.024 |
2 | 1000000 | 0.023 |
3 | 1100000 | 0.022 |
1 | 1428571 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 185538 | 4 |
0.028 | 77772 | 1 |
0.029 | 400000 | 1 |
0.030 | 57805 | 2 |
0.031 | 132328 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
GPR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online